BE884760A - Comprime secable permettant une liberation controlee et retardee de la substance active - Google Patents

Comprime secable permettant une liberation controlee et retardee de la substance active

Info

Publication number
BE884760A
BE884760A BE0/201740A BE201740A BE884760A BE 884760 A BE884760 A BE 884760A BE 0/201740 A BE0/201740 A BE 0/201740A BE 201740 A BE201740 A BE 201740A BE 884760 A BE884760 A BE 884760A
Authority
BE
Belgium
Prior art keywords
controlled
active substance
delayed release
breakable tablet
breakable
Prior art date
Application number
BE0/201740A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BE884760A publication Critical patent/BE884760A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
BE0/201740A 1979-08-16 1980-08-13 Comprime secable permettant une liberation controlee et retardee de la substance active BE884760A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7514/79A CH648754A5 (en) 1979-08-16 1979-08-16 Pharmaceutical slow release tablet

Publications (1)

Publication Number Publication Date
BE884760A true BE884760A (fr) 1981-02-13

Family

ID=4326338

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/201740A BE884760A (fr) 1979-08-16 1980-08-13 Comprime secable permettant une liberation controlee et retardee de la substance active

Country Status (4)

Country Link
JP (1) JPS5659708A (fr)
BE (1) BE884760A (fr)
CH (1) CH648754A5 (fr)
ZA (1) ZA805015B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH052574Y2 (fr) * 1986-02-24 1993-01-22
ES2127737T3 (es) * 1991-09-10 1999-05-01 Takeda Chemical Industries Ltd Tableta divisible.
UA67802C2 (uk) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
GB0030340D0 (en) * 2000-12-13 2001-01-24 Sorex Ltd Briquettes
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2005112898A1 (fr) * 2004-05-21 2005-12-01 Accu-Break Pharmaceuticals, Inc. Comprimes pharmaceutiques possedant un segment relativement inactif
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5259413B2 (ja) * 2005-11-18 2013-08-07 エーシーシーユー−ブレイク テクノロジーズ,インク. セグメント化した薬の剤形
EP2029116A4 (fr) * 2006-06-19 2012-07-04 Accu Break Technologies Inc Formes pharmaceutiques sécables
BRPI0906467C1 (pt) * 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
KR101690094B1 (ko) 2008-05-09 2016-12-27 그뤼넨탈 게엠베하 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법
PE20121067A1 (es) 2009-07-22 2012-09-05 Gruenenthal Chemie Forma de dosificacion de liberacion controlada extruida por fusion en caliente
WO2011009604A1 (fr) 2009-07-22 2011-01-27 Grünenthal GmbH Forme galénique inviolable stabilisée à l’oxydation
WO2012028319A1 (fr) 2010-09-02 2012-03-08 Grünenthal GmbH Forme pharmaceutique inviolable comportant un sel inorganique
CA2808541C (fr) 2010-09-02 2019-01-08 Gruenenthal Gmbh Forme pharmaceutique inviolable comportant un polymere anionique
KR20140053158A (ko) 2011-07-29 2014-05-07 그뤼넨탈 게엠베하 즉시 약물 방출을 제공하는 탬퍼-저항성 정제
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
CA2864949A1 (fr) 2012-02-28 2013-09-06 Grunenthal Gmbh Forme pharmaceutique inviolable comprenant un compose pharmacologiquement actif et un polymere anionique
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JPWO2013187395A1 (ja) * 2012-06-12 2016-02-04 第一三共株式会社 容易な服用性と分割性を有する錠剤
CA2913209A1 (fr) 2013-05-29 2014-12-04 Grunenthal Gmbh Forme dosifiee inviolable a profil de liberation bimodale
EP3003279A1 (fr) 2013-05-29 2016-04-13 Grünenthal GmbH Forme pharmaceutique inviolable contenant une ou plusieurs particules
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
WO2015087561A1 (fr) * 2013-12-09 2015-06-18 第一三共株式会社 Comprimé sécable
JP5719479B1 (ja) * 2013-12-09 2015-05-20 第一三共株式会社 容易な分割性を有する錠剤
CA2947786A1 (fr) 2014-05-12 2015-11-19 Grunenthal Gmbh Formulation pour capsule a liberation immediate resistant aux manipulations illicites comprenant du tapentadol
WO2015181059A1 (fr) 2014-05-26 2015-12-03 Grünenthal GmbH Microparticules protégées contre une libération massive dans l'éthanol
JP2018517676A (ja) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時放出および溶媒抽出に対する耐性を有する改変防止製剤
WO2017042325A1 (fr) 2015-09-10 2017-03-16 Grünenthal GmbH Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus

Also Published As

Publication number Publication date
ZA805015B (en) 1981-08-26
JPS6361928B2 (fr) 1988-11-30
JPS5659708A (en) 1981-05-23
CH648754A5 (en) 1985-04-15

Similar Documents

Publication Publication Date Title
BE884760A (fr) Comprime secable permettant une liberation controlee et retardee de la substance active
PT71706A (en) Divisible tablet having controlled and delayed release of the active substance
NL7803309A (nl) Farmaceutisch preparaat van het uit meervoudige eenheden bestaande type met gestuurde afgifte van het werkzame bestanddeel.
MX5502E (es) Procedimiento para la preparacion de eteres y esteres de oximas
MX8352A (es) Procedimiento para la elaboracion de sulfonilureas y producto resultante.
NL300007I2 (nl) Preparaat voor de gereguleerde afgifte van een werkzame stof.
NO790865L (no) Derivater av jodpropargyl samt fremgangsmaate til fremstilling av samme
ES497517A0 (es) Procedimiento de preparacion de nuevos iminoacidos y de sus derivados.
BR8201133A (pt) Dispositivo para liberacao controlada de um ou mais materiais ativos
ES489628A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- piridina y piperidina
NL7800014A (nl) Geneesmiddel voor het verbeteren van de doorbloeding en wondgenezing.
AR217465A1 (es) Lapiz pa arcosmetica y procedimiento para la elaboracion de dicho lapiz
ES493995A0 (es) Procedimiento para la preparacion de eteres oximicos y este-res oximicos de eteres difenilicos
IT1093048B (it) Procedimento per la produzione dei fertilizzanti inodori e prollati di urea diziandiammide
AR221355A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil y pirrolidinilmetil-benzamidas
SE7707999L (sv) Silikatpolymert material samt forfarande for tillverkning av detsamma
NL7805742A (nl) Flitslampstelsel voor het verschaffen van zeer sterke hoorbare en zichtbare signalen.
NO800664L (no) Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater
BE857122A (fr) Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active
ES489894A0 (es) Perfeccionamientos en aparatos para la elaboracion de sena- les de video
NL7802835A (nl) Vormpreparaat en werkwijze voor het vormen van voortbrengsels daaruit.
NL7809652A (nl) Werkwijze en inrichting voor het ononderbroken ineen- draaien van strengvormig materiaal van grotere dwars- doorsnede.
FI823322A0 (fi) Anordning foer urvattning av naturfuktig torv
NO811628L (no) Fremgangsmaate for fremstilling av karbapenam- og karbapen-2-em-derivater.
BE886759A (nl) Farmaceutische preparaten van therapeutische waarde voor het behandelen van acute longoedemen sommige shocktoestanden en hyperfibrinolyse

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: NOVARTIS A.G.

Effective date: 20000813